Similar articles

• The suppressive activities of alprenolol against deslanoside-induced cardiotoxicities in guinea pigs.

  Otorii T, Kojima T, Nito M. Otorii T, et al. Jpn Circ J. 1973 Mar;37(3):297-303. doi: 10.1253/jcj.37.297. Jpn Circ J. 1973. PMID: 4146992 No abstract available.
• [Arrhythmias. 7. Treatment with beta-receptor blocking agents].

  Johnsson G, Persson S. Johnsson G, et al. Lakartidningen. 1971 Jun 14;68:Suppl II:100-. Lakartidningen. 1971. PMID: 4398809 Review. Swedish. No abstract available.
• [Beta adrenergic receptor blockaders in the treatment of cardiac arrhythmias].

  Benchimol AB, Saad EA. Benchimol AB, et al. Hospital (Rio J). 1970 Jul;78(1):1-33. Hospital (Rio J). 1970. PMID: 4394930 Review. Portuguese. No abstract available.
• Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.

  Flórez J, Arconada JA. Flórez J, et al. Arch Int Pharmacodyn Ther. 1971 Mar;190(1):199-207. Arch Int Pharmacodyn Ther. 1971. PMID: 4396347 No abstract available.
• [Experimental study of the anti-arrhythmic activity of some beta-blocking drugs].

  Arcangeli A, Sarcinelli L, Brusadelli S. Arcangeli A, et al. Acta Anaesthesiol. 1968:Suppl 8:335+. Acta Anaesthesiol. 1968. PMID: 4393552 Italian. No abstract available.